stockrowDIH Holding US, Inc.
DHAIDIH Holding US, Inc.’s revenue for fiscal 2025 (year ended March 2025) was $62.9 million, down 2.50% from fiscal 2024.
- Revenue
- −30.7%
- EPS
- +43.1%
- Free cash flow
- −167.9%
Quarter to March 2025, against a year earlier
Follow DHAI
Alert me
DIH Holding US, Inc. (DHAI) EV/Sales
As of 30 October 2026, DIH Holding US, Inc. (DHAI) trades at a EV/Sales of 0.1×. Over the past ten years it has ranged from 0.0× (June 2024) to 2.2× (July 2024); the current reading is higher than 64% of that period. That is below the Medical Devices industry median of 2.8× and below the Healthcare sector median of 3.6×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 0.3× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Mar 2025 | 0.3× | (65.63%) |
| Dec 2024 | 0.8× | (25.91%) |
| Sep 2024 | 1.1× | (32.76%) |
| Jun 2024 | 1.7× | — |
| 3 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| ICCM IceCure Medical Ltd. compare | −3.8× |
| CODX Co-Diagnostics, Inc. compare | −3.5× |
| NUVOQ Holdco Nuvo Group D.G Ltd. compare | n/m |
| BJDX Bluejay Diagnostics, Inc. compare | n/m |
| DHAI DIH Holding US, Inc. | 0.1× |
| NXL Nexalin Technology, Inc. compare | 0.2× |
| IVF INVO Fertility, Inc compare | 0.2× |
| GCTK GlucoTrack, Inc. compare | 4.2× |
| ADGM Adagio Medical Holdings, Inc. compare | 30.6× |
| Medical Devices industry median | 2.8× |
| Healthcare sector median | 3.6× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)